• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AI Demand Drives Wiley's First Quarter 2026 Results

    9/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary
    Books
    Consumer Discretionary
    Get the next $WLY alert in real time by email

    Wiley (NYSE:WLY), a leading global provider of authoritative content, data-driven insights, and knowledge services for the advancement of science and learning, today reported results for the first quarter ended July 31, 2025.

    FIRST QUARTER SUMMARY

    • GAAP performance vs. prior year: Revenue of $397 million vs. $404 million due to foregone revenue from divested businesses, Operating Income of $31 million up 7%, and Diluted Earnings Per Share (EPS) of $0.22 vs. (-$0.03) in prior year
    • Adjusted Results at constant currency in line with expectations: Adjusted Revenue of $397 million up 1%, Adjusted Operating Income of $34 million down 2%, Adjusted EBITDA of $70 million down 3%, and Adjusted EPS of $0.49 up 2%
    • Growth in Research revenue (+5% at constant currency) driven by AI licensing projects and open access growth offsetting timing of prior year journal renewals
    • Executed landmark AI licensing project with large tech company on behalf of Wiley publisher partners; announced strategic partnership with Anthropic to accelerate AI integration across scholarly research
    • Increased dividend for the 32nd consecutive year and share repurchases to $14 million; Board approved $250 million share repurchase authorization, a 25% increase over its 2020 authorization

    MANAGEMENT COMMENTARY

    "We continue to see strong demand trends in research as we open up new growth pathways in AI and corporate R&D," said Matthew Kissner, President and CEO. "Wiley is now a recognized leader in AI licensing and innovation, executing projects for multi-national corporations and strategically partnering with top AI innovators. At the same time, we continue to drive operational excellence across the organization, reaching important milestones in our multi-stage research publishing platform launch and expanding AI innovation across our product portfolio. Given leading indicators, the strength of our recurring revenue models and open access programs, and anticipated cost savings, we remain fully confident in our Fiscal 2026 outlook."

    FINANCIAL SUMMARY

    Please see accompanying financial tables for more detail.

    Research

    • Q1 Research revenue of $282 million was up 6% as reported and 5% at constant currency driven by AI licensing revenue of $16 million (vs. $1 million in prior year period) and open access growth offsetting an unfavorable comparison to prior year due to the timing of journal renewals, as well as softness in ancillary material. Wiley continues to see strong demand to publish with article submissions and output growing by 25% and 13%, respectively, with robust growth across all key geographies. Note, it takes approximately six months for a submitted article to be published.
    • Q1 Adjusted EBITDA of $80 million was up 2% as reported and at constant currency due to revenue growth partially offset by AI mix (higher royalties for the partner portion of the AI licensing agreement) and the timing of costs. Adjusted EBITDA margin for the quarter was 28.3% vs. 29.3% in the prior year period.

    Learning

    • Q1 Learning revenue of $115 million was down 7% as reported and 8% at constant currency largely due to $16 million of AI licensing revenue in the prior year (vs. $13 million this quarter) and market-related softness in Professional.
    • Q1 Adjusted EBITDA of $31 million for the quarter was down 7% as reported and at constant currency due to lower revenue. Adjusted EBITDA margin was 27.4%, up slightly over prior year.

    Corporate Expenses

    "Corporate Expenses" are the portion of shared services costs not allocated to segments.

    • Q1 Corporate Expenses rose 4% on an Adjusted EBITDA basis at constant currency driven primarily by costs related to strategic consulting projects (now complete), enterprise modernization, and other one-time items. Wiley expects Corporate Expenses to decline starting in Q2 as cost savings ramp up.

    EPS

    • GAAP EPS of $0.22 compared to a ($0.03) loss in the prior year period, which was impacted by a $0.33/share, non-cash income tax adjustment.
    • Adjusted EPS of $0.49 was up 2% at constant currency mainly due to lower interest expense from lower rates.

    BALANCE SHEET, CASH FLOW, AND CAPITAL ALLOCATION

    • Net Debt-to-EBITDA Ratio (Trailing Twelve Months) at quarter end was 1.9 compared to 2.0 in the year-ago period.
    • Net Cash Used in Operating Activities was $85 million compared to $89 million in the prior year period. Note, Wiley's regular use of cash in the first half of the fiscal year is driven by the timing of cash collections for annual journal renewals, which are concentrated in Q3 and Q4.
    • Free Cash Flow less Product Development Spending was a use of $100 million compared to a use of $107 million in the prior year. Capex was $15 million compared to $18 million.
    • Returns to Shareholders: Wiley allocated $32 million toward dividends and repurchases this quarter, up approximately $1 million from the prior year period. In Q1, the Company acquired approximately 332,000 shares at an average cost of $42.22/share and raised its dividend for the 32nd consecutive year. In June, the Wiley Board of Directors approved a $250 million share repurchase authorization, a 25% increase over its 2020 authorization.
    • Divestiture Proceeds: During the quarter, Wiley received approximately $120 million in cash proceeds related to the University Services divestiture, with the total outstanding note paid in full. Wiley has utilized these proceeds to further reduce its debt.

    FISCAL 2026 OUTLOOK

    Based on leading demand and output indicators, the success of calendar year 2025 journal renewals, and anticipated cost savings, Wiley is reaffirming its full year outlook.

    Metric

    Fiscal 2024 Results

    Fiscal 2025 Results

    Fiscal 2026 Outlook

    Adj. Revenue

    $1,617M

    $1,660M

    Low to mid-single digit growth

    Adj. EBITDA Margin

    22.8%

    24%

    25.5% to 26.5%

    Adj. EPS

    $2.78

    $3.64

    $3.90 to $4.35

    Free Cash Flow

    $114M

    $126M

    Approximately $200M

    Note, growth outlook is comprehensive and includes adverse variances, including AI revenue in Fiscal 2025. Adjusted metrics exclude impact of divestitures, which were primarily completed in Fiscal 2024 with remainder completed in first half of Fiscal 2025. Approximately $17 million of divestiture-related revenue was recorded in Fiscal 2025.

    EARNINGS CONFERENCE CALL

    Scheduled for today, September 4 at 10:00 am (ET). Access webcast at Investor Relations at investors.wiley.com, or directly at http://events.q4inc.com/attendee/819546756. U.S. callers, please dial (888) 210-3346 and enter the participant code 2521217#. International callers, please dial (646) 960-0253 and enter the participant code 2521217#.

    ABOUT WILEY

    Wiley (NYSE:WLY) is a leading global provider of authoritative content, data-driven insights, and knowledge services that advance science and learning. For over 200 years, we've empowered researchers, learners and institutions worldwide to drive progress and solve the world's most pressing challenges.

    Learn more at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

    NON-GAAP FINANCIAL MEASURES

    Wiley provides non-GAAP financial measures and performance results such as "Adjusted EPS," "Adjusted Operating Income and Margin," "Adjusted EBITDA and Margin," "Adjusted Income before Taxes," "Adjusted Income Tax Provision," "Adjusted Effective Income Tax Rate," "Free Cash Flow less Product Development Spending," "Adjusted Revenue," and results on a Constant Currency basis to assess underlying business performance and trends. Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information. We have not provided our 2026 outlook for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with U.S. GAAP.

    FORWARD-LOOKING STATEMENTS

    This release contains certain forward-looking statements concerning the Company's operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements. Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors. Such factors include, but are not limited to: (i) the level of investment in new technologies and products; (ii) subscriber renewal rates for the Company's journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key online retailers; (vi) the seasonal nature of the Company's educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) the Company's ability to protect its copyrights and other intellectual property worldwide (ix) the ability of the Company to successfully integrate acquired operations and realize expected opportunities; (x) the ability to realize operating savings over time and in fiscal year 2026 in connection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; (xiii) our ability to leverage artificial intelligence technologies in our products and services, including generative artificial intelligence, large language models, machine learning, and other artificial intelligence tools; and (xiv) other factors detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect subsequent events.

    CATEGORY: EARNINGS RELEASES

    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1)(2)
    CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (LOSS)
    (in USD thousands, except per share information)
    (unaudited)
     
    Three Months Ended
    July 31,

    2025

    2024

    Revenue, net

    $

    396,800

     

    $

    403,809

     

    Costs and expenses:
    Cost of sales

     

    109,259

     

     

    109,220

     

    Operating and administrative expenses

     

    240,330

     

     

    248,819

     

    Restructuring and related charges

     

    3,038

     

     

    3,870

     

    Amortization of intangible assets

     

    13,210

     

     

    12,927

     

    Total costs and expenses

     

    365,837

     

     

    374,836

     

     
    Operating income

     

    30,963

     

     

    28,973

     

    As a % of revenue

     

    7.8

    %

     

    7.2

    %

     
    Interest expense

     

    (11,042

    )

     

    (12,787

    )

    Net foreign exchange transaction (losses) gains

     

    (971

    )

     

    234

     

    Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale(3)

     

    (1,116

    )

     

    5,801

     

    Other (expense) income, net

     

    (127

    )

     

    782

     

     
    Income before taxes

     

    17,707

     

     

    23,003

     

     
    Provision for income taxes

     

    6,007

     

     

    24,439

     

    Effective tax rate

     

    33.9

    %

     

    106.2

    %

    Net income (loss)

    $

    11,700

     

    $

    (1,436

    )

    As a % of revenue

     

    2.9

    %

     

    -0.4

    %

     
    Earnings (loss) per share
    Basic

    $

    0.22

     

    $

    (0.03

    )

    Diluted(4)

    $

    0.22

     

    $

    (0.03

    )

     
    Weighted average number of common shares outstanding
    Basic

     

    53,377

     

     

    54,377

     

    Diluted(4)

     

    53,966

     

     

    54,377

     

     
     
    Notes:
    (1) The supplementary information included in this press release for the three months ended July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) All amounts are approximate due to rounding.
     
    (3) We recorded net pretax (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:
    Three Months Ended

    July 31,

    2025

    2024

    University Services

    $

    (934

    )

    $

    1,489

     

    CrossKnowledge

     

    -

     

     

    4,360

     

    Wiley Edge

     

    -

     

     

    (168

    )

    Tuition Manager

     

    -

     

     

    120

     

    Other disposition activity

     

    (182

    )

     

    -

     

    Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale

    $

    (1,116

    )

    $

    5,801

     

     
    On January 1, 2024, we completed the sale of University Services. On June 5, 2025, Wiley entered into an agreement to sell the Seller Note, the fiscal year 2026 earnout, the TVG Investment, and agreed on the fiscal year 2025 earnout for total cash consideration of $119.5 million, which was fully paid in June 2025. As a result of the sale of these assets, we recognized an additional pretax loss of $0.9 million in the three months ended July 31, 2025.
     
    (4) In calculating diluted net loss per common share for the three months ended July 31, 2024, our diluted weighted average number of common shares outstanding excludes the effect of unvested restricted stock units and other stock awards as the effect was antidilutive. This occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    RECONCILIATION OF US GAAP MEASURES to NON-GAAP MEASURES
    (in USD thousands, except per share information)
    (unaudited)
     
    Reconciliation of US GAAP Earnings (Loss) per Share to Non-GAAP Adjusted EPS
    Three Months Ended
    July 31,

    2025

    2024

    US GAAP Earnings (Loss) Per Share - Diluted

    $

    0.22

     

    $

    (0.03

    )

    Adjustments:
    Restructuring and related charges

     

    0.05

     

     

    0.06

     

    Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (3)

     

    -

     

     

    (0.05

    )

    Amortization of acquired intangible assets (4)

     

    0.20

     

     

    0.20

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale (5)

     

    0.02

     

     

    (0.09

    )

    Held for Sale or Sold segment Adjusted Net Loss (5)

     

    -

     

     

    0.04

     

    Income tax adjustments

     

    -

     

     

    0.33

     

    EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (6)

     

    -

     

     

    0.01

     

    Non-GAAP Adjusted Earnings Per Share - Diluted

    $

    0.49

     

    $

    0.47

     

     
    Reconciliation of US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes
    Three Months Ended
    July 31,

    2025

    2024

    US GAAP Income Before Taxes

    $

    17,707

     

    $

    23,003

     

    Pretax Impact of Adjustments:
    Restructuring and related charges

     

    3,038

     

     

    3,870

     

    Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (3)

     

    (440

    )

     

    (2,591

    )

    Amortization of acquired intangible assets (4)

     

    13,210

     

     

    12,969

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale (5)

     

    1,116

     

     

    (5,801

    )

    Held for Sale or Sold segment Adjusted Loss Before Taxes (5)

     

    -

     

     

    2,519

     

    Non-GAAP Adjusted Income Before Taxes

    $

    34,631

     

    $

    33,969

     

     
    Reconciliation of US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate
     
    US GAAP Income Tax Provision

    $

    6,007

     

    $

    24,439

     

    Income Tax Impact of Adjustments (7)
    Restructuring and related charges

     

    519

     

     

    749

     

    Foreign exchange gains on intercompany transactions, including the write off of certain cumulative translation adjustments (3)

     

    (750

    )

     

    (390

    )

    Amortization of acquired intangible assets (4)

     

    2,068

     

     

    1,809

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale (5)

     

    54

     

     

    (925

    )

    Held for Sale or Sold segment Adjusted Tax Benefit (5)

     

    -

     

     

    372

     

    Income Tax Adjustments
    Impact of valuation allowance on the US GAAP effective tax rate (8)

     

    166

     

     

    (18,030

    )

    Non-GAAP Adjusted Income Tax Provision

    $

    8,064

     

    $

    8,024

     

     
    US GAAP Effective Tax Rate

     

    33.9

    %

     

    106.2

    %

    Non-GAAP Adjusted Effective Tax Rate

     

    23.3

    %

     

    23.6

    %

     
    Notes:
    (1) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three months ended July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) All amounts are approximate due to rounding.
     
    (3) In fiscal year 2023 due to the closure of our operations in Russia, the Russia entity was deemed substantially liquidated. The formal liquidation was completed in the fourth quarter of fiscal year 2025. In the three months ended July 31, 2024, we wrote off an additional $0.5 million of cumulative translation adjustments in earnings. This amount is reflected in Net foreign exchange transaction (losses) gains on our Condensed Consolidated Statements of Net Income (Loss).
     
    (4) Reflects the amortization of intangible assets established on the opening balance sheet for an acquired business. This includes the amortization of intangible assets such as developed technology, customer relationships, tradenames, etc., which is reflected in the "Amortization of intangible assets" line in the Condensed Consolidated Statements of Net Income (Loss). It also includes the amortization of acquired product development assets, which is reflected in Cost of sales in the Condensed Consolidated Statements of Net Income (Loss).
     
    (5) We recorded net pretax loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:
    Three Months Ended

    July 31,

    2025

    2024

    University Services

    $

    934

     

    $

    (1,489

    )

    CrossKnowledge

     

    -

     

     

    (4,360

    )

    Wiley Edge

     

    -

     

     

    168

     

    Tuition Manager

     

    -

     

     

    (120

    )

    Other disposition activity

     

    182

     

     

    -

     

    Net pretax loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

    $

    1,116

     

    $

    (5,801

    )

     
    We recorded income tax benefit (provision) on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:
    Three Months Ended

    July 31,

    2025

    2024

    University Services

    $

    -

     

    $

    -

     

    CrossKnowledge

     

    -

     

     

    -

     

    Wiley Edge

     

    -

     

     

    (895

    )

    Tuition Manager

     

    -

     

     

    (30

    )

    Other disposition activity

     

    54

     

     

    -

     

    Benefit (provision) on sale of businesses, assets, and impairment charges related to assets held-for-sale

    $

    54

     

    $

    (925

    )

    In addition, our Adjusted EPS excludes the Adjusted Net Income or Loss of our Held for Sale or Sold segment.
     
    (6) Represents the impact of using diluted weighted-average number of common shares outstanding (55.0 million for the three months ended July 31, 2024) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.
     
    (7) For the three months ended July 31, 2025 and 2024, respectively, substantially all of the tax impact was from deferred taxes.
     
    (8) In the three months ended July 31, 2025 and 2024, there was an impact on the US GAAP effective tax rate due to the valuation allowance on deferred tax assets in the US of $0.2 million and $(18.0) million, respectively.
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1)
    RECONCILIATION OF US GAAP NET INCOME (LOSS) TO NON-GAAP EBITDA AND ADJUSTED EBITDA
    (in USD thousands)
    (unaudited)
     
    Three Months Ended
    July 31,

    2025

    2024

    Net Income (Loss)

    $

    11,700

     

    $

    (1,436

    )

    Interest expense

     

    11,042

     

     

    12,787

     

    Provision for income taxes

     

    6,007

     

     

    24,439

     

    Depreciation and amortization

     

    36,446

     

     

    37,253

     

    Non-GAAP EBITDA

     

    65,195

     

     

    73,043

     

    Restructuring and related charges

     

    3,038

     

     

    3,870

     

    Net foreign exchange transaction losses (gains)

     

    971

     

     

    (234

    )

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    1,116

     

     

    (5,801

    )

    Other expense (income), net

     

    127

     

     

    (782

    )

    Held for Sale or Sold segment Adjusted EBITDA (2)

     

    -

     

     

    2,519

     

    Non-GAAP Adjusted EBITDA

    $

    70,447

     

    $

    72,615

     

    Adjusted EBITDA Margin

     

    17.8

    %

     

    18.6

    %

     
    Notes:
    (1) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors. The supplementary information included in this press release for the three months ended July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.

     
    (2) Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA.
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    SEGMENT RESULTS
    (in USD thousands)
    (unaudited)
     
    % Change
    Three Months Ended July 31, Favorable (Unfavorable)

     

    2025

     

     

    2024

     

    Reported Constant Currency
    Research:
    Revenue, net
    Research Publishing

    $

    231,827

     

    $

    230,951

     

    0

    %

    -1

    %

    Research Solutions

     

    49,865

     

     

    34,358

     

    45

    %

    44

    %

    Total Revenue, net

    $

    281,692

     

    $

    265,309

     

    6

    %

    5

    %

     
    Non-GAAP Adjusted Operating Income

    $

    56,248

     

    $

    55,216

     

    2

    %

    3

    %

    Depreciation and amortization

     

    23,385

     

     

    22,559

     

    -4

    %

    -2

    %

    Non-GAAP Adjusted EBITDA

    $

    79,633

     

    $

    77,775

     

    2

    %

    2

    %

    Adjusted EBITDA margin

     

    28.3

    %

     

    29.3

    %

     
    Learning:
    Revenue, net
    Academic

    $

    55,472

     

    $

    59,964

     

    -7

    %

    -8

    %

    Professional

     

    59,636

     

     

    64,350

     

    -7

    %

    -8

    %

    Total Revenue, net

    $

    115,108

     

    $

    124,314

     

    -7

    %

    -8

    %

     
    Non-GAAP Adjusted Operating Income

    $

    21,655

     

    $

    22,500

     

    -4

    %

    -4

    %

    Depreciation and amortization

     

    9,844

     

     

    11,294

     

    13

    %

    13

    %

    Non-GAAP Adjusted EBITDA

    $

    31,499

     

    $

    33,794

     

    -7

    %

    -7

    %

    Adjusted EBITDA margin

     

    27.4

    %

     

    27.2

    %

     
    Held for Sale or Sold:
    Total Revenue, net

    $

    -

     

    $

    14,186

     

    # #
     
    Non-GAAP Adjusted Operating Loss

    $

    -

     

    $

    (2,519

    )

    # #
    Depreciation and amortization

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    -

     

    $

    (2,519

    )

    # #
    Adjusted EBITDA margin

     

    0.0

    %

     

    -17.8

    %

     
    Corporate Expenses:
    Non-GAAP Adjusted Corporate Expenses

    $

    (43,902

    )

    $

    (42,354

    )

    -4

    %

    -3

    %

    Depreciation and amortization

     

    3,217

     

     

    3,400

     

    5

    %

    6

    %

    Non-GAAP Adjusted EBITDA

    $

    (40,685

    )

    $

    (38,954

    )

    -4

    %

    -4

    %

     
    Consolidated Results:
    Revenue, net

    $

    396,800

     

    $

    403,809

     

    -2

    %

    -3

    %

    Less: Held for Sale or Sold Segment (3)

     

    -

     

     

    (14,186

    )

    # #
    Adjusted Revenue, net

    $

    396,800

     

    $

    389,623

     

    2

    %

    1

    %

     
    Operating Income

    $

    30,963

     

    $

    28,973

     

    7

    %

    9

    %

    Adjustments:
    Restructuring charges

     

    3,038

     

     

    3,870

     

    21

    %

    21

    %

    Held for Sale or Sold Segment Adjusted Operating Loss (3)

     

    -

     

     

    2,519

     

    # #
    Non-GAAP Adjusted Operating Income

    $

    34,001

     

    $

    35,362

     

    -4

    %

    -2

    %

    Adjusted Operating Income margin

     

    8.6

    %

     

    9.1

    %

    Depreciation and amortization

     

    36,446

     

     

    37,253

     

    2

    %

    4

    %

    Less: Held for Sale or Sold Segment depreciation and amortization (3)

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    70,447

     

    $

    72,615

     

    -3

    %

    -3

    %

    Adjusted EBITDA margin

     

    17.8

    %

     

    18.6

    %

     
    Notes:
    (1) The supplementary information included in this press release for the three months ended July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) All amounts are approximate due to rounding.
     
    (3) Our Adjusted Revenue, Adjusted Operating Income and Adjusted EBITDA excludes the impact of our Held for Sale or Sold segment Revenue, Adjusted Operating Income or Loss and Adjusted EBITDA results.
     
    # Variance greater than 100%
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1)
    CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
    (in USD thousands)
    (unaudited)
     
    July 31, April 30,

    2025

    2025

    Assets:
    Current assets
    Cash and cash equivalents

    $

    81,850

    $

    85,882

    Accounts receivable, net

     

    220,317

     

    228,410

    Inventories, net

     

    21,951

     

    22,875

    Prepaid expenses and other current assets

     

    96,177

     

    102,717

    Total current assets

     

    420,295

     

    439,884

     
    Technology, property and equipment, net

     

    152,430

     

    162,125

    Intangible assets, net

     

    580,331

     

    595,044

    Goodwill

     

    1,117,827

     

    1,121,505

    Operating lease right-of-use assets

     

    63,626

     

    66,128

    Other non-current assets

     

    189,823

     

    306,780

    Total assets

    $

    2,524,332

    $

    2,691,466

     
    Liabilities and shareholders' equity:
    Current liabilities
    Accounts payable

    $

    36,384

    $

    60,948

    Accrued royalties

     

    112,535

     

    109,765

    Short-term portion of long-term debt

     

    10,000

     

    10,000

    Contract liabilities

     

    361,677

     

    462,693

    Accrued employment costs

     

    44,706

     

    93,117

    Short-term portion of operating lease liabilities

     

    17,512

     

    18,282

    Other accrued liabilities

     

    66,029

     

    66,051

    Total current liabilities

     

    648,843

     

    820,856

    Long-term debt

     

    818,272

     

    789,435

    Accrued pension liability

     

    71,954

     

    71,899

    Deferred income tax liabilities

     

    104,105

     

    105,145

    Operating lease liabilities

     

    78,200

     

    81,482

    Other long-term liabilities

     

    69,899

     

    70,443

    Total liabilities

     

    1,791,273

     

    1,939,260

    Shareholders' equity

     

    733,059

     

    752,206

    Total liabilities and shareholders' equity

    $

    2,524,332

    $

    2,691,466

     
    Notes:
    (1) The supplementary information included in this press release for July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1)
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (in USD thousands)
    (unaudited)
     
    Three Months Ended
    July 31,

    2025

    2024

    Operating activities:
    Net income (loss)

    $

    11,700

     

    $

    (1,436

    )

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    1,116

     

     

    (5,801

    )

    Amortization of intangible assets

     

    13,210

     

     

    12,927

     

    Amortization of product development assets

     

    3,792

     

     

    4,476

     

    Depreciation and amortization of technology, property, and equipment

     

    19,444

     

     

    19,850

     

    Other noncash charges

     

    19,274

     

     

    20,370

     

    Net change in operating assets and liabilities

     

    (153,541

    )

     

    (139,098

    )

    Net cash used in operating activities

     

    (85,005

    )

     

    (88,712

    )

     
    Investing activities:
    Additions to technology, property, and equipment

     

    (12,005

    )

     

    (14,502

    )

    Product development spending

     

    (2,890

    )

     

    (3,351

    )

    Businesses acquired in purchase transactions, net of cash acquired

     

    -

     

     

    (915

    )

    Net cash proceeds (transferred) related to the sale of businesses and assets

     

    115,168

     

     

    (6,387

    )

    Acquisitions of publication rights and other

     

    (1,417

    )

     

    1,348

     

    Net cash provided by (used in) investing activities

     

    98,856

     

     

    (23,807

    )

     
    Financing activities:
    Net debt borrowings

     

    30,591

     

     

    143,749

     

    Cash dividends

     

    (18,985

    )

     

    (19,184

    )

    Purchases of treasury shares

     

    (13,500

    )

     

    (12,500

    )

    Other

     

    (15,030

    )

     

    (10,476

    )

    Net cash (used in) provided by financing activities

     

    (16,924

    )

     

    101,589

     

     
    Effects of exchange rate changes on cash, cash equivalents and restricted cash

     

    (959

    )

     

    798

     

     
    Change in cash, cash equivalents and restricted cash for period

     

    (4,032

    )

     

    (10,132

    )

     
    Cash, cash equivalents and restricted cash - beginning

     

    85,932

     

     

    99,543

     

    Cash, cash equivalents and restricted cash - ending

    $

    81,900

     

    $

    89,411

     

     
    CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (2)
     
    Three Months Ended
    July 31,

    2025

    2024

    Net cash used in operating activities

    $

    (85,005

    )

    $

    (88,712

    )

    Less: Additions to technology, property, and equipment

     

    (12,005

    )

     

    (14,502

    )

    Less: Product development spending

     

    (2,890

    )

     

    (3,351

    )

    Free cash flow less product development spending

    $

    (99,900

    )

    $

    (106,565

    )

     
    Notes:
    (1) The supplementary information included in this press release for the three months ended July 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplemental information.

    JOHN WILEY & SONS, INC.

    EXPLANATION OF USAGE OF NON-GAAP PERFORMANCE MEASURES

    In this earnings release and supplemental information, management may present the following non-GAAP performance measures:

    • Adjusted Earnings Per Share (Adjusted EPS);
    • Free Cash Flow less Product Development Spending;
    • Adjusted Revenue;
    • Adjusted Operating Income and margin;
    • Adjusted Income Before Taxes;
    • Adjusted Income Tax Provision;
    • Adjusted Effective Tax Rate;
    • EBITDA, Adjusted EBITDA and margin; and
    • Results on a constant currency basis.

    Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well as for internal reporting and forecasting purposes, when publicly providing our outlook, to evaluate our performance and calculate incentive compensation.

    We present these non-GAAP performance measures in addition to US GAAP financial results because we believe that these non-GAAP performance measures provide useful information to certain investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose.

    The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Operating Income. We present both Adjusted Operating Income and Adjusted EBITDA for each of our reportable segments as we believe Adjusted EBITDA provides additional useful information to certain investors and financial analysts for operational trends and comparisons over time. It removes the impact of depreciation and amortization expense, as well as presents a consistent basis to evaluate operating profitability and compare our financial performance to that of our peer companies and competitors.

    For example:

    • Adjusted EPS, Adjusted Revenue, Adjusted Operating Income and margin, Adjusted Income Before Taxes, Adjusted Income Tax Provision, Adjusted Effective Tax Rate, EBITDA, and Adjusted EBITDA and margin provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.
    • Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends, and fund share repurchases and acquisitions.
    • Results on a constant currency basis remove distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance excluding the impact of foreign currency (or at constant currency), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.

    In addition, we have historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing our operating margins and net income, and in comparing our financial performance to that of our peer companies and competitors. Based on interactions with investors, we also believe that our non-GAAP performance measures are regarded as useful to our investors as supplemental to our US GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures.

    We have not provided our 2026 outlook for the most directly comparable US GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with US GAAP.

    Non-GAAP performance measures do not have standardized meanings prescribed by US GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under US GAAP. The adjusted metrics have limitations as analytical tools, and should not be considered in isolation from, or as a substitute for, US GAAP information. It does not purport to represent any similarly titled US GAAP information and is not an indicator of our performance under US GAAP. Non-GAAP financial metrics that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-GAAP measures.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250904941401/en/

    Brian Campbell

    Investor Relations

    [email protected]

    201.748.6874

    Get the next $WLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLY
    $WLYB

    CompanyDatePrice TargetRatingAnalyst
    John Wiley & Sons Inc.
    $WLY
    9/8/2022Market Perform → Market Outperform
    CJS Securities
    John Wiley & Sons Inc.
    $WLY
    8/29/2022Market Outperform → Market Perform
    CJS Securities
    More analyst ratings

    $WLY
    $WLYB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Singh Inder M

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:48:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Mcdaniel Raymond W

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:47:08 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Madden Karen N

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:45:44 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wiley upgraded by CJS Securities

    CJS Securities upgraded Wiley from Market Perform to Market Outperform

    9/8/22 9:07:27 AM ET
    $WLY
    Books
    Consumer Discretionary

    Wiley downgraded by CJS Securities

    CJS Securities downgraded Wiley from Market Outperform to Market Perform

    8/29/22 10:00:26 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kissner Matthew S bought $502,028 worth of Class A Common (16,550 units at $30.33), increasing direct ownership by 181% to 25,705 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 6:04:59 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4) (Amendment)

    4/A - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 2:50:35 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/18/23 4:30:50 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    SEC Filings

    View All

    John Wiley & Sons Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/10/25 11:21:47 AM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 10-Q filed by John Wiley & Sons Inc.

    10-Q - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/5/25 9:40:56 AM ET
    $WLY
    Books
    Consumer Discretionary

    John Wiley & Sons Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/4/25 11:00:14 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Leadership Updates

    Live Leadership Updates

    View All

    Wiley Appoints Katya Andresen to Board of Directors

    Chief Digital & Analytics Officer for The Cigna Group has strong background in technology and AI innovation Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Katya Andresen, chief digital & analytics officer for The Cigna Group, to its Board of Directors. Andresen's background spans technology, data, analytics, and AI innovation across Fortune 500 companies and emerging enterprises. She has led significant initiatives at The Cigna Group and Capital One and successfully transformed Cricket Media by launching a profitable data and digital licensing business. "As we continue to advance our priorities

    6/30/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Appoints Craig Albright as Executive Vice President and Chief Financial Officer

    Seasoned finance executive brings a proven track record in driving profitable growth, improving operational efficiency, and optimizing cash flow Wiley (NYSE:WLY), one of the world's largest publishers and a global leader in research and education, today announced the appointment of Craig Albright as executive vice president and chief financial officer, effective June 26, 2025. Chris Caridi, who has led Wiley's finance organization as interim chief financial officer, will continue with the role of senior vice president, chief accounting officer and finance transformation leader. Albright joins Wiley with over 30 years of global leadership expertise in finance, strategy, and consulting ro

    6/23/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

    MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. At MilliporeSigma, Madden shapes the Technology Roadmap and long-term R&D strategy, systematically exploring emerging opportunities that lead to breakthrough innovations. She leads the Life Science Innovation Board, ensuring a balance o

    3/5/25 8:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Financials

    Live finance-specific insights

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    11/8/24 3:02:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/23/24 5:04:46 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/18/24 8:42:58 AM ET
    $WLY
    Books
    Consumer Discretionary